These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2265765

  • 1. Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy.
    Larsen M, Hommel E, Parving HH, Lund-Andersen H.
    Graefes Arch Clin Exp Ophthalmol; 1990; 228(6):505-9. PubMed ID: 2265765
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of captopril on blood pressure and kidney function in normotensive insulin dependent diabetics with nephropathy.
    Parving HH, Hommel E, Damkjaer Nielsen M, Giese J.
    BMJ; 1989 Aug 26; 299(6698):533-6. PubMed ID: 2507061
    [Abstract] [Full Text] [Related]

  • 7. Blood-retina barrier permeability in diabetes during acute ACE-inhibition.
    Engler CB, Parving HH, Mathiesen ER, Larsen M, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1991 Oct 26; 69(5):581-5. PubMed ID: 1776410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A controlled clinical trial of angiotensin-converting enzyme inhibition in type I diabetic nephropathy: study design and patient characteristics. The Collaborative Study Group.
    Bain R, Rohde R, Hunsicker LG, McGill J, Kobrin S, Lewis EJ.
    J Am Soc Nephrol; 1992 Oct 26; 3(4 Suppl):S97-103. PubMed ID: 1457767
    [Abstract] [Full Text] [Related]

  • 12. Probenecid inhibition of the outward transport of fluorescein across the human blood-retina barrier.
    Engler CB, Sander B, Larsen M, Koefoed P, Parving HH, Lund-Andersen H.
    Acta Ophthalmol (Copenh); 1994 Dec 26; 72(6):663-7. PubMed ID: 7747571
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitor treatment for young normotensive diabetic subjects: a two-year trial.
    Chase HP, Garg SK, Harris S, Hoops S, Jackson WE, Holmes DL.
    Ann Ophthalmol; 1993 Aug 26; 25(8):284-9. PubMed ID: 8239321
    [Abstract] [Full Text] [Related]

  • 14. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP, Raskovic M, Schimke E.
    Dtsch Med Wochenschr; 1994 Jun 03; 119(22):796-800. PubMed ID: 8205941
    [Abstract] [Full Text] [Related]

  • 15. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Insua A, Ribstein J, Mimran A.
    Postgrad Med J; 1988 Jun 03; 64 Suppl 3():59-62; discussion 90-2. PubMed ID: 3074298
    [Abstract] [Full Text] [Related]

  • 16. Effects of captopril on diabetic nephropathy in hypertensive women.
    Gonzalez-Sicilia de Llamas L, Garcia Alberola A, Lafuente Lopez-Herrera M, Fuente Jimenez T, Fernandez Pardo J, Hernandez Cascales J.
    Eur J Clin Pharmacol; 1991 Jun 03; 41(5):405-9. PubMed ID: 1761066
    [Abstract] [Full Text] [Related]

  • 17. Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy.
    Romanelli G, Giustina A, Bossoni S, Caldonazzo A, Cimino A, Cravarezza P, Giustina G.
    Diabetes; 1990 Nov 03; 39(11):1333-8. PubMed ID: 2227107
    [Abstract] [Full Text] [Related]

  • 18. Effects of imidapril and captopril on streptozotocin-induced diabetic nephropathy in mice.
    Katoh M, Ohmachi Y, Kurosawa Y, Yoneda H, Tanaka N, Narita H.
    Eur J Pharmacol; 2000 Jun 23; 398(3):381-7. PubMed ID: 10862828
    [Abstract] [Full Text] [Related]

  • 19. Comparative effect of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.
    Mimran A, Insua A, Ribstein J, Bringer J, Monnier L.
    Diabetes Care; 1988 Jun 23; 11(10):850-3. PubMed ID: 3073076
    [Abstract] [Full Text] [Related]

  • 20. Diabetic nephropathy and pregnancy: the effect of ACE inhibitors prior to pregnancy on fetomaternal outcome.
    Hod M, van Dijk DJ, Karp M, Weintraub N, Rabinerson D, Bar J, Peled Y, Erman A, Boner G, Ovadia J.
    Nephrol Dial Transplant; 1995 Dec 23; 10(12):2328-33. PubMed ID: 8808235
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.